Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Pediatr Hematol Oncol ; 44(2): e487-e492, 2022 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-33181582

RESUMEN

Mucositis, a painful and debilitating condition, is a common side effect of chemotherapy. The role of tramadol in the treatment of mucositis in pediatric patients has not yet been determined. In this retrospective study, we evaluate whether tramadol as single agent achieved a reduction of pain intensity among oncologic children admitted for mucositis. In total, 34 of 54 (63%) episodes were treated with tramadol alone and achieved adequate pain relief. Tramadol's side effects were mild and manageable.


Asunto(s)
Antineoplásicos , Mucositis , Tramadol , Analgésicos Opioides , Antineoplásicos/uso terapéutico , Niño , Humanos , Mucositis/inducido químicamente , Mucositis/tratamiento farmacológico , Dolor/inducido químicamente , Dolor/tratamiento farmacológico , Estudios Retrospectivos , Tramadol/efectos adversos
2.
J Investig Med High Impact Case Rep ; 7: 2324709619862311, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31319728

RESUMEN

High-dose methotrexate is used to treat a range of adult and childhood cancers including osteosarcoma. Significant neurotoxicity is reported in 1% to 4.5% of patients treated with high-dose methotrexate and can present in a wide variety of symptoms. We present a case of a 14-year-old boy with a recent diagnosis of osteosarcoma who presented to the emergency department with status epilepticus, altered mental status, and very high fever secondary to methotrexate neurotoxicity. We review current literature and discuss some controversies related to this state. We also describe high fever as one of the possible symptoms associated with this condition and suggest using specific magnetic resonance imaging sequence to uncover abnormal findings related to this state. Since high-dose methotrexate is not a rare treatment in this era, we believe that in addition to oncologists, emergency department and intensive care providers should be aware of the potential role of methotrexate in causing significant neurotoxicity and include it in the differential diagnosis when treating a patient presenting with new neurological symptoms in the setting of recent high-dose methotrexate treatment.


Asunto(s)
Antimetabolitos Antineoplásicos/toxicidad , Encefalopatías/inducido químicamente , Fiebre/inducido químicamente , Metotrexato/toxicidad , Estado Epiléptico/inducido químicamente , Adolescente , Antimetabolitos Antineoplásicos/uso terapéutico , Neoplasias Óseas/tratamiento farmacológico , Servicio de Urgencia en Hospital , Humanos , Masculino , Metotrexato/uso terapéutico , Osteosarcoma/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...